BY Christopher Karlsson
-
Zealand Pharma CEO opens up to acquisitions: “We are entering a whole new phase”
After concentrating on cooperation contracts for the business’s very own funds, Zealand Pharma will certainly currently additionally look towards outside enhancements to its …
-
Lars Rebien is the new chairman at Novo Nordisk
In addition, the pharmaceutical business additionally assigned a brand-new vice-chair at the amazing basic conference on Friday mid-day. The consultations can be found in the wake …
-
PensionDanmark will vote in favor of new Novo Nordisk board
However, the company believes that the process leading up to Friday’s general meeting at Novo Nordisk has given rise to some concern in relation to good corporate governance.
-
Novo Nordisk expects three-year tariff exemption under Trump deal
The EU participated in a profession arrangement with the United States previously this year that enforces a 15% toll on drugs, to name a few items.
-
Pfizer files another lawsuit: Accuses Metsera owners of conspiring with Novo Nordisk
This is the 2nd suit Pfizer has actually submitted versus Novo Nordisk and Metsera after Novo Nordisk outbid the United States pharmaceutical firm on Thursday.
-
Novo Nordisk wants to hijack billion-dollar deal: Pfizer is ready to use all legal means at its disposal
Pfizer calls Novo Nordisk’s effort to obtain Metsera both “negligent” and “unmatched.”
-
Gubra boss is tight-lipped about reasons for significant downgrade
Henrik Blou, CEO of Gubra, is reluctant to offer any suggestions as to what lies behind the macroeconomic uncertainty experienced by the company’s customers.
-
Gubra boss is tight-lipped about reasons for significant downgrade
Henrik Blou, Chief Executive Officer of Gubra, hesitates to provide any kind of tips regarding what exists behind the macroeconomic unpredictability experienced by the firm’s…
-
Zealand Pharma CEO plans to use bulging coffers to secure launch of crown jewel
As an outcome of the collaboration contract authorized with Roche, Zealand Pharma has accessibility to a large amount of cash. A great deal of it will certainly be made use of for …
-
Zealand Pharma CEO plans to use bulging coffers to secure launch of crown jewel
As a result of the partnership agreement signed with Roche, Zealand Pharma has access to a large sum of money. A lot of it will be used for the company’s weight loss candidate, pet…
